Email ID
Sign me in automatically next time
Merck BioVentures: where biosimilars make a difference

Mike Kamarck, the president of Merck BioVentures, tells ScripIntelligence Managing Editor, John Hodgson, how pharma companies are shaping the biosimilars rules in the US, why Merck...
23 June 2011
John Hodgson

Please Login to read the full article.
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36